Moderna Shares Jump Almost 7% on Positive Remarks at Healthcare Conference
Moderna Shares Jump Almost 7% on Positive Remarks
at Healthcare Conference
$Moderna (MRNA.US)$ shares are up almost 7% on Friday, following optimistic remarks made by a senior executive at a healthcare conference about the company's pipeline and financial position.
$Moderna (MRNA.US)$ 周五股价上涨了近7%,此前一位高级管理人员在医疗保健会议上对公司的管道和财务状况发表了乐观的言论。
Lavina Talukdar, Moderna's head of investor relations, shared at the Jefferies London Healthcare Conference on Thursday that the Cambridge, Mass.-based company expects its revenue to support its business by 2028.
Moderna投资者关系主管拉维娜·塔鲁克达尔周四在马萨诸塞州剑桥的杰富瑞伦敦医疗保健会议上分享了这一点。总部位于总部的公司预计,到2028年,其收入将支持其业务。
"We expect to end the year with $9 billion in cash," Talukdar said, according to a transcript provided by AlphaSense. "Our investment rate ... is declining each year going forward. And we anticipate that $9 billion will have us launching 10 products over the next three years that will start to contribute to revenue a year after approval."
根据AlphaSense提供的记录,塔鲁克达尔说:“我们预计今年年底将有90亿美元的现金。”“我们的投资率... 今后每年都在下降。我们预计,在未来三年中,90亿美元将使我们推出10种产品,这些产品将在获得批准一年后开始增加收入。”
Along with Friday's rise, shares in the last two trading sessions have gained 11%; however, this year they are down almost 60% as the demand for COVID-19 vaccines declines.
随着周五的上涨,最近两个交易日的股价上涨了11%;但是,由于对 COVID-19 疫苗的需求下降,今年股价下跌了近60%。